AstraZeneca to Invest $2 Billion in US Biologics Facility
Fourth major US manufacturing investment announced this year, advancing AstraZeneca’s historic $50 billion commitment to medicines manufacturing and R&D.
investment
DuPont Breaks Ground on Lubricants Manufacturing Plant in China
New capacity of specialty lubricants to accelerate business growth and innovation in the region.
Thermo Fisher Opens Advanced Therapies Collaboration Center in Philadelphia
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness.
Novartis Launches $23 Billion North Carolina Manufacturing Hub
Novartis plans to establish a flagship manufacturing hub in North Carolina by 2027-2028 as part of a $23 billion investment in US infrastructure.
Ineos Announces €250 Million Investment to Strengthen French Industry at Lavéra
Ineos has launched a major investment at Lavera to regenerate and modernize one of France’s most important industrial sites, safeguarding 10,000 jobs, with support from the French State.
Nouryon Opens New Innovation Center in Shanghai
Nouryon has opened a new innovation center in Shanghai to boost localized innovation, customer collaboration, and sustainable development in key industries across China and the Asia Pacific region.
Curia Invests $4 Million to Enhance Sterile API Manufacturing
Curia has completed a $4 million upgrade to its sterile API manufacturing suites in Valladolid, Spain, to enhance product quality, safety, and regulatory compliance.
SK Pharmteco Invests $6.1 Million in Peptide Manufacturing at California Facility
SK Pharmteco has announced a $6.1 million investment to expand its Rancho Cordova, California, facility with new lab and kilo-scale capabilities for solid-phase peptide synthesis and purification.
Aenova Expands Fill & Finish Capacities at its Latina site
Aenova will install an additional filling and manufacturing line at the Latina, Italy, site. This expansion is an important step to meet the increasing global demand for the production of biologics.
Sharp Services Invests $100 Million in US and European Facilities
Investments will bolster clinical and commercial capacity in US and Europe facilities for injectable and oral solid dose packaging, and sterile filling.
Cambrex Invests $120 Million to Expand US API Manufacturing
Cambrex announced a $120 million investment to expand its API manufacturing capacity at its Charles City, Iowa, facility by 40%.
ACG Invests $200 Million in US Hard-Shell Capsule Manufacturing
The investment will focus on developing gelatin and HPMC facilities, creating over 200 new jobs, and strengthening ACG’s 25-year presence in the US, with operations expected to begin in early 2027.
Brenntag Specialties Opens New Innovation & Application Center for Food & Nutrition in UK
The Leeds Innovation & Application Center is the newest of the now 71 Brenntag Specialties innovation centers globally, 31 of which focus on Food & Nutrition.
Roquette Opens Pharmaceutical Innovation Center in Brazil
Roquette has inaugurated a new Pharmaceutical Innovation Center in Brazil to support advanced research and development in the region’s pharmaceutical sector.
Clariant Expands Production Capacities in Daya Bay
Clariant successfully completes its CHF 100 million investment in the Daya Bay plant in China, with the second production line becoming fully operational in November.
Polyvantis Opens Shanghai Technology Center
Polyvantis has opened a new Technology Center in Shanghai, China, to unite R&D, commercial, and manufacturing teams and accelerate innovation for optical and electrical film solutions.
Fujifilm Biotechnologies Opens its Commercial-Scale Cell Culture US Manufacturing Site
Fujifilm Biotechnologies has opened one of North America's largest commercial-scale cell culture biomanufacturing sites in Holly Springs, North Carolina, US.
Henkel Expands US Facility to Boost EV and Electronics Manufacturing
Henkel has doubled the size of its South Dakota plant to increase production of thermal management materials for the electric vehicle and electronics markets.
Arkema Opens Battery Dry Coating Laboratory
Arkema has inaugurated a new laboratory in Normandy dedicated to dry coating processes for battery electrodes, aiming to advance sustainable manufacturing by reducing energy use and developing new battery solutions.
AbbVie Breaks Ground on US API Manufacturing Facility
New state-of-the-art active pharmaceutical ingredient (API) facility in North Chicago will manufacture immunology, oncology, and neuroscience medicines.
Siegfried Opens cGMP Viral Vectors Manufacturing Facility
Dinamiqs, a Siegfried company specialized in viral vector design and manufacturing, inaugurated its new cGMP manufacturing facility.
Lilly to Build $6.5 Billion US Pharmaceutical Plant
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Houston, Texas.
BASF Launches CO₂-Free Steam Heat Pump Project at Ludwigshafen
BASF and cooperation partner GIG Karasek have celebrated the symbolic ground-breaking ceremony for one of the world's largest industrial heat pumps for CO2-free steam generation at the Ludwigshafen site.
Merck Opens Life Science Production Plant in Ireland
Merck's first climate-neutral production facility has opened at its Blarney site in Cork, Ireland. The €150 million new building is part of the group's €440 million investment program in Ireland.
Solvay Restructures German Operations, Invests €25 Million
Solvay strengthens its competitiveness in Germany through portfolio realignment and investments.
GSK to Invest $30 Billion in US R&D and Manufacturing
Includes $1.2 billion in manufacturing facilities, AI, and advanced digital technologies, creating hundreds of highly skilled US jobs.
LGC Opens $100 Million Pharma Synthesis Center in Canada
LGC Group has inaugurated a CAD$100 million (€61.5 million) Organic Chemistry Synthesis Centre of Excellence in Vaughan, Canada.
Gilead Breaks Ground on New US Manufacturing Hub
New Bay Area building marks significant progress as part of Gilead's $32 billion US investment.
Honeywell’s Quantinuum Secures $600 Million Funding, Gains Nvidia as Investor
Honeywell’s Quantinuum has raised $600 million at a $10 billion valuation, with Nvidia and other key investors backing the company to accelerate development of advanced quantum technologies and global partnerships.
Vioneo and ECI Group to Build World’s First Fossil-Free LDPE Plant in Belgium
Vioneo awards ECI Group contract to build world’s first LDPE plant using entirely fossil-free feedstock.
Genentech and Roche Break Ground on US Manufacturing Facility
The $700 million project is part of Genentech and Roche’s $50 billion investment in U.S. manufacturing, infrastructure and R&D
Cambrex Expands Peptide Manufacturing Capabilities in US
CDMO Cambrex announced that Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts
Arkema Invests $60 Million in New Fluorospecialties Production Unit in the US
With the start-up of its production unit in Kentucky, Arkema develops its low Global Warming Potential (GWP) fluorospecialties to meet demand for more sustainable solutions in building insulation and thermal management.
AbbVie to Acquire Gilgamesh Pharmaceutical’s Psychedelic Drug for $1.2B
Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD).
Sumitomo Scales Up Ethanol-to-Propylene Process
Sumitomo Chemical has constructed and begun operation of a pilot facility at the Sodegaura site of its Chiba Works for its new proprietary process to produce propylene directly from ethanol.
